• OPEN AN ACCOUNT
Indian Indices
Sensex
78,639.03 544.39
( 0.70%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
63,705.00 -657.02
(-1.02%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Visaka Industries Ltd
Industry :  Cement Products
BSE Code
ISIN Demat
Book Value()
509055
INE392A01021
96.6998638
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VISAKAIND
46.06
736.25
EPS(TTM)
Face Value()
Div & Yield %
1.85
2
1.41
 

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter
May 16,2026
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.6061.23 46 235.47198.32 19
OPM %24.7223.83 -15.5415.87 -
PBDT21.1914.69 44 42.2837.58 13
PBT20.2113.84 46 38.6534.47 12
NP14.5210.40 40 30.1726.70 13